Optimized for pharma/biopharma to deliver a deeper understanding of cellular function SANTA CLARA, Calif, — Agilent Technologies Inc. (NYSE: A) today announced the release of the Agilent Seahorse XF Pro Analyzer, featuring new pharma-oriented workflow solutions incorporating advanced experimental design and analysis tools. With enhanced performance, more robust and efficient workflows, and an optimized user experience, the […]
Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic Acquisitions Dr. Michael Egholm, Former CTO of Danaher Life Sciences, to Assume Role of CEO and Join Board of Directors Following Close; Alex Kim, Former President of Milliken & Company’s Healthcare Division, to Assume Role of COO Eli Casdin, CIO […]
Q2 Solutions, Azenta Life Sciences, and CellCarta to support large-scale clinical research trials for global pharmaceutical partners PLEASANTON, Calif. — 10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the expansion of its 10x Certified Service Provider (CSP) Network to include three leading clinical research organizations […]
Highlights: Novel 3D biology technology supported by a new €800,000 grant from the Austrian Research Promotion Agency (FFG) Investing to double R&D footprint in Salzburg, Austria Adding customer support roles in Italy, Spain, and Portugal San Jose, C alif.– Molecular Devices, LLC. , a leading provider of high-performance life science solutions, is expanding its R&D facility in […]
Improved access to induced pluripotent stem cells for allogeneic cell therapy applications SEATTLE — Pluristyx, Inc., an advanced therapy tools and services biotechnology company, panCELLa, a privately held biotechnology company, and Implant Therapeutics, a developer of genetically engineered stem cells, today announced they have entered into a manufacturing and distribution strategic alliance that offers cell […]
Collaboration will enable transparent, cGMP, and scalable manufacture of custom cell culture media Cytiva, a global life sciences leader, and Nucleus Biologics, LLC, The Cell Performance Company™, have signed a collaboration agreement on custom media formulation and fulfillment solutions for the cell and gene therapy industry. Utilizing Nucleus Biologics’ proprietary platform, Cytiva customers will have […]
Partnership will optimize manufacturing of extracellular vesicles (EVs) using scalable and continuous bioprocessing technologies to propel the commercialization of regenerative therapies at affordable costs. Proof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms RoosterBio to leverage scalable, continuous bioprocessing technologies to deliver regenerative therapies at reduced timelines and costs, […]
Cytiva welcomes Nucleus Biologics’ proven and powerful AI-powered interface that brings state-of-the-art cell media design and supply to the Cell and Gene Therapy Industry. Cell and gene therapies are critically reliant on the growth and maintenance of a viable and efficacious cell population. It is proven that cell culture media can have a profound impact […]
Ms. Moy brings 30 years of HR leadership experience at high-performing companies MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Marilee Moy as Chief People Officer. Ms. Moy has more than 30 years of HR leadership experience at high-performing life sciences and technology companies. She […]
Proof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms. RoosterBio to leverage scalable, continuous bioprocessing technologies to deliver regenerative therapies at reduced timelines and costs, improving access for patients. FREDERICK, Md. — Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable viral production, announces today […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
